Browsing by Keyword : Diabetes Mellitus, Type 2/blood

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 32 of 32

Pub YearTitleAuthor(s)
201610-year trajectory of beta-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study조남한
2015A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes.이관우
2005Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.김대중, 송경은, 이관우
2018ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels김대중
2018Blood adiponectin levels are not associated with risk of cardiovascular events in patients with type 2 diabetes김대중, 김혜진, 이관우, 전자영, 하경화, 한승진
2018Can persistent organic pollutants distinguish between two opposite metabolic phenotypes in lean Koreans?김대중, 하경화
2018Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study김대중
2007Clinical characteristics of Korean type 2 diabetic patients in 2005.김대중, 이관우
2016Comparison of screening scores for diabetes and prediabetes김대중
2007Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.김대중, 김혜진, 이관우
2017Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes강두경, 김혜진, 한승진
2007Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.김대중, 이관우
2018Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial이관우
2018Glycated hemoglobin A1c as a screening test for detecting type 2 diabetes mellitus in obese children and adolescents이해상, 황진순
2008Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients.김혜진
2015Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial.이관우
2017Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study김대중, 김혜진, 이관우, 조남한, 한승진
2016Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study김대중
2015Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.이관우
2018Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial이관우
2017Low-Dose Persistent Organic Pollutants Impair Insulin Secretory Function of Pancreatic beta-Cells: Human and In Vitro Evidence김대중
2016Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus조남한
2015Performance of HbA1c for the prediction of diabetes in a rural community in Korea.김대중
2008Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.김혜진
2008Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis.강엽, 김혜진, 최성이, 한승진
2016Severe Periodontitis Is Associated with Insulin Resistance in Non-abdominal Obese Adults지숙
2018Sodium-glucose co-transporter-2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: A nationwide population-based cohort study김대중, 김혜진, 이관우, 전자영, 한승진
2008Staged diabetes management according to individual patient insulin resistance and beta-cell function ameliorates glycaemic control in type 2 diabetes mellitus.김대중
2006The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients.김혜진
2007The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment.김혜진
2006The long-term effects of rosiglitazone on serum lipid concentrations and body weight.김혜진
2014Thoracic-to-hip circumference ratio as a novel marker of type 2 diabetes, independent of body mass index and waist-to-hip ratio, in Korean adults.조남한
1

Browse